Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10716892 | 0.93 | TAAR1 (0.45) | TAAR1GABRA1GABRB2TP53GAA | |
| SCHEMBL29458957 | 0.90 | — | — | |
| SCHEMBL40576 | 0.90 | — | — | |
| SCHEMBL5489439 | 0.90 | TAAR1 (0.54) | TAAR1GABRA1GABRB2MAPTPTGS2 | |
| Dimethylamine SCHEMBL4576084 | 0.88 | TAAR1 (0.48) | TAAR1GABRA1GABRB2GAAPTGS2 | |
| Ammonia Solution, Strong SCHEMBL9453011 | 0.87 | TAAR1 (0.52) | TAAR1GABRA1GABRB2MAPTPTGS2 | |
| O-Xylene SCHEMBL9356149 | 0.87 | TSHR (0.56) | TAAR1GABRA1GABRB2MAPTPTGS2 | |
| Ammonia Solution, Strong SCHEMBL5005672 | 0.87 | TAAR1 (0.52) | TAAR1GABRA1GABRB2MAPTPTGS2 | |
| SCHEMBL31498537 | 0.87 | TAAR1 (0.52) | TAAR1GABRA1GABRB2MAPTPTGS2 | |
| SCHEMBL5157331 | 0.87 | TAAR1 (0.52) | TAAR1GABRA1GABRB2MAPTPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2138231-B1 | METHOD OF MODIFYING ZEOLITE CATALYST | SAUDI BASIC IND CORP (SA) | 2018-08-22 | — | — | EP | disclosed |
| CN-103934018-A | Heavy aromatics processing catalyst and process of using the same | EXXONMOBIL CHEM PATENTS INC | 2014-07-23 | — | — | CN | disclosed |
| EP-1812391-A2 | PROCESS OF MAKING FENTANYL INTERMEDIATES | Boehringer Ingelheim Chemicals, Inc. (US) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006055321-A2 | PROCESS OF MAKING FENTANYL INTERMEDIATES | BOEHRINGER INGELHEIM CHEMICALS, INC. (US) | 2006-05-26 | — | — | WO | disclosed |
| US-20060100438-A1 | Process of making fentanyl intermediates | BOEHRINGER INGELHEIM CHEMICALS, INC. (US) | 2006-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100438-A1 | Process of making fentanyl intermediates | OPRK1, OPRD1, OPRM1 | TAAR1 2135/4885GABRA1 266/4885GABRB2 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.